Seminars in Oncology
Volume 31, Issue 4 , Pages 513-529 , August 2004

Staging and preoperative evaluation of upper gastrointestinal malignancies

  • Eddie K. Abdalla

      Affiliations

    • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Peter W.T. Pisters

      Affiliations

    • Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    • Corresponding Author InformationAddress reprint requests to Peter W.T. Pisters, MD, FACS, Department of Surgical Oncology, Box 444, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4095 USA

References 

  1. Devesa S, Blot W, Fraumeni J. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053
  2. Daly J, Fry W, Little AG, et al.  Esophageal cancer (results of an American College of Surgeons patient care evaluation study). J Am Coll Surg. 2000;190:562–572
  3. Greene FL. AJCC Cancer Staging Manual. (ed 6). New York, NY: Springer-Verlag; 2002;
  4. Hennessy T, Keeling P. Adenocarcinoma of the esophagus and cardia. J Thorac Cardiovasc Surg. 1987;94:64–68
  5. Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg. 1989;76:136–139
  6. Clark G, Smyrk T, Burdiles P, et al.  Is Barretts metaplasia the source of adenocarcinomas of the cardia?. Arch Surg. 1994;129:609–614
  7. Siewert J, Stein H. Carcinoma of the cardia (Carcinoma of the gastroesophageal junction; classification, pathology and extent of resection). Dis Esophagus. 1996;9:173–182
  8. Siewert J, Stein H. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457–1459
  9. SEER Cancer Statistics Review, 1975–2000. 2003; http://seer.cancer.gov/csr/1975_2000/results_merged/sect_08_esphagus.pdf. Accessed
  10. Orringer M, Marshall B, Iannettoni M. Transhiatal esophagectomy (Clinical experience and refinements). Ann Surg. 1999;230:392–400
  11. Bonavina L, Via A, Incarbone R, et al.  Results of surgical therapy in patients with Barrett’s adenocarcinoma. World J Surg. 2003;27:1062–1066
  12. Chu K, Law S, Fok M, et al.  A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg. 1997;174:320–324
  13. Walsh T, Noonan N, Hollywood D, et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–467
  14. Stein H, Sendler A, Fink U, et al.  Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am. 2000;80:659–682
  15. Stein H, Brucher B, Sendler A, et al.  Esophageal cancer (patient evaluation and pre-treatment staging). Surg Oncol. 2001;10:103–111
  16. Stein H, Feith M, Siewert J. Cancer of the esophagogastric junction. Surg Oncol. 2000;1:35–41
  17. Pera M, Trastek V, Carpenter H, et al.  Influence of pancreatic and biliary reflux on the development of esophageal-carcinoma. Ann Thorac Surg. 1993;55:1386–1393
  18. Hameeteman W, Tytgat G, Houthoff H, et al.  Barretts esophagus—Development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96:1249–1256
  19. Chandrasoma P. Pathological basis of gastroesophageal reflux disease. World J Surg. 2003;27:986–993
  20. Sampliner R. Prevention of adenocarcinoma by reversing Barrett’s esophagus with mucosal ablation. World J Surg. 2003;27:1026–1029
  21. Werner M, Flejou JF, Hainaut P, et al.  In:  Hamilton SR,  Aaltonen L editor. Adenocarcinoma of the oesophagus (World Health Organization Classification of Tumors Pathology and Genetics—Tumors of the Digestive System). Lyon, France: IARC Press; 2000;p. 20–25
  22. Clark G. Effect of Helicobacter pylori infection in Barrett’s esophagus and the genesis of esophageal adenocarcinoma. World J Surg. 2003;27:994–998
  23. National Comprehensive Cancer Network . NCCN practice guidelines for upper gastrointestinal carcinomas. Oncology (Huntingt). 1998;12:179–223
  24. Lightdale C. Esophageal cancer. Am J Gastroenterol. 1999;94:20–29
  25. Kim K, Park S, Kim B, et al.  Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg. 2001;71:290–294
  26. Kato H, Kuwano H, Nakajima M, et al.  Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–928
  27. Rasanen J, Sihvo E, Knuuti M, et al.  Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol. 2003;10:954–960
  28. Flamen P, Lerut A, Van Cutsem E, et al.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202–3210
  29. Peters J, Hoeft S, Heimbucher J, et al.  Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. Arch Surg. 1994;129:534–539
  30. Chandawarkar R, Kakegawa T, Fujita H, et al.  Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer. J Surg Oncol. 1996;61:214–217
  31. Sugarbaker D, Jaklitsch M, Liptay M. Thoracoscopic staging and surgical therapy for esophageal cancer. Chest. 1995;107(suppl 6):S218–S223
  32. Iyer R, Silverman P, Tamm E, et al.  Imagine in oncology from the University of Texas M. D. Anderson Cancer Center—Diagnosis, staging, and follow-up of esophageal cancer. Am J Roentgenol. 2003;181:785–793
  33. Lerut T, Flamen P, Ectors N, et al.  Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction—A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg. 2000;232:743–751
  34. Anderson D, Campbell S, Park K. Accuracy of laparoscopic ultrasonography in the staging of upper gastrointestinal malignancy. Br J Surg. 1996;83:1424–1428
  35. Block M, Patterson G, Sundaresan R, et al.  Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg. 1997;64:770–776
  36. Flanagan F, Dehdashti F, Siegel B, et al.  Staging of esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography. Am J Roentgenol. 1997;168:417–424
  37. Lightdale C. Positron emission tomography (Another useful test for staging esophageal cancer). J Clin Oncol. 2000;18:3199–3201
  38. Pauwels E, McCready V, Stoot J, et al.  The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med. 1998;25:277–305
  39. Rosch T. Endosonographic staging of esophageal cancer (A review of literature results). Gastrointest Endosc Clin North Am. 1995;5:537–547
  40. VanDam J. Endosonographic evaluation of the patient with esophageal cancer. Chest. 1997;112(suppl 4):S184–S190
  41. Caletti G, Fusaroli P, Bocus P. Endoscopic ultrasonography. Digestion. 1998;59:509–529
  42. Fockens P, VandenBrande J, vanDullemen H, et al.  Endosonographic T-staging of esophageal carcinoma (A learning curve). Gastrointest Endosc. 1996;44:58–62
  43. Zuccaro G, Rice T, Goldblum J, et al.  Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol. 1999;94:906–912
  44. Bergman J, Fockens P. Endoscopic ultrasonography in patients with gastro-esophageal cancer. Eur J Ultrasound. 1999;10:127–138
  45. Eloubeidi M, Wallace M, Reed C, et al.  The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer (A single-center experience). Gastrointest Endosc. 2001;54:714–719
  46. Krasna M, Reed C, Nedzwiecki D, et al.  CALGB 9380 (A prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer). Ann Thorac Surg. 2001;71:1073–1079
  47. Wallace M, Nietert P, Earle C, et al.  An analysis of multiple staging management strategies for carcinoma of the esophagus (Computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy). Ann Thorac Surg. 2002;74:1026–1032
  48. Bonavina L, Incarbone R, Lattuada E, et al.  Preoperative laparoscopy in management of patients with carcinoma of the esophagus and of the esophagogastric junction. J Surg Oncol. 1997;65:171–174
  49. Wakelin S, Deans C, Crofts T, et al.  A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol. 2002;41:161–167
  50. Bryan R, Cruickshank N, Needham S, et al.  Laparoscopic peritoneal lavage in staging gastric and oesophageal cancer. Eur J Surg Oncol. 2001;27:291–297
  51. Baisi A, Bonavina L, Peracchia A. Bronchoscopic staging of squamous cell carcinoma of the upper thoracic esophagus. Arch Surg. 1999;134:140–143
  52. Baisi A, Bonavina L. Preoperative bronchoscopic biopsies and staging. Chest. 2002;121:2081–2082
  53. Riedel M, Hauck R, Stein H, et al.  Preoperative bronchoscopic assessment of airway invasion by esophageal cancer—A prospective study. Chest. 1998;113:687–695
  54. Riedel M, Stein H, Mounyam L, et al.  Extensive sampling improves preoperative bronchoscopic assessment of airway invasion by supracarinal esophageal cancer—A prospective study in 166 patients. Chest. 2001;119:1652–1660
  55. Kajitani T. The general rules for gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg. 1981;11:127–139
  56. Curtis R, Kennedy B, Myers M, et al.  Evaluation of AJC stomach cancer staging using the SEER population. Semin Oncol. 1985;12:21–31
  57. Keighley M, Moore J, Roginski C, et al.  Incidence and prognosis of N4 node involvement in gastric cancer. Br J Surg. 1984;71:863–866
  58. Allum W, Powell D, McConkey D, et al.  Gastric cancer (a 25-year review). Br J Surg. 1989;76:535–540
  59. Allum W, Hallissey M, Ward L, et al.  A controlled, prospective, randomized trial of adjuvant chemotherapy or radiotherapy in resectable gastric-cancer—Interim report. Br J Cancer. 1989;60:739–744
  60. Fielding J, Roginski C, Ellis D, et al.  Clinicopathological staging of gastric cancer. Br J Surg. 1984;71:677–680
  61. Kennedy B. T N M classification for stomach cancer. Cancer. 1970;26:971–983
  62. Stomach. In:  Fleming ID,  Cooper JS,  Henson DE, et al. editor. AJCC Cancer Staging Manual. Philadelphia, PA: Lippincott-Raven; 1997;p. 71–76
  63. Wanebo H, Kennedy B, Chmiel J, et al.  Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg. 1993;218:583–592
  64. Roder J, Bottcher K, Siewert J, et al.  Prognostic factors in gastric-carcinoma—Results of the German Gastric-Carcinoma Study 1992. Cancer. 1993;72:2089–2097
  65. Maruyama K, Sasako M, Kinoshita T, et al.  Surgical treatment for gastric cancer (The Japanese approach). Semin Oncol. 1996;23:360–368
  66. Ichikura T, Tomimatsu S, Okusa Y, et al.  Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol. 1993;11:1894–1900
  67. Isozaki H, Okajima K, Kawashima Y, et al.  Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol. 1993;53:247–251
  68. Fujii K, Isozaki H, Okajima K, et al.  Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system. Br J Surg. 1999;86:685–689
  69. Hundahl S, Phillips J, Menck H. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy (Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis). Cancer. 2000;88:921–932
  70. Bunt A, Hermans J, van de Velde C, et al.  Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. J Clin Oncol. 1996;14:2289–2294
  71. Davies J, Chalmers A, Sue-Ling H, et al.  Spiral computed tomography and operative staging of gastric carcinoma (A comparison with histopathological staging). Gut. 1997;41:314–319
  72. Kuntz C, Herfarth C. Imaging diagnosis for staging of gastric cancer. Semin Surg Oncol. 1999;17:96–102
  73. Minami M, Kawauchi N, Itai Y, et al.  Gastric tumors (Radiologic-pathologic correlation and accuracy of T staging with dynamic CT). Radiology. 1992;185:173–178
  74. Rossi M, Broglia L, Maccioni F, et al.  Hydro-CT in patients with gastric cancer (Preoperative radiologic staging). Eur Radiol. 1997;7:659–664
  75. Fukuya T, Honda H, Hayashi T, et al.  Lymph-node metastases (Efficacy for detection with helical CT in patients with gastric cancer). Radiology. 1995;197:705–711
  76. Halvorsen R, Yee J, McCormick V. Diagnosis and staging of gastric cancer. Semin Oncol. 1996;23:325–335
  77. Abdalla EK, Kaw M, Pisters P. Invasive techniques for palliation of advanced gastric cancer. In:  Posner M,  Vokes E,  Weichselbaum R editor. American Cancer Society Atlas of Clinical Oncology (Cancer of the Upper Gastrointestinal Tract). Ontario, Canada: Decker; 2002;p. 308–321
  78. Fockens P. Gastrointestinal cancer staging by endoscopic ultrasonography. Abdom Imaging. 1998;23:543–545
  79. Lightdale C. Endoscopic ultrasonography in the diagnosis, staging and follow-up of esophageal and gastric cancer. Endoscopy. 1992;24(suppl 1):297–303
  80. Akahoshi K, Misawa T, Fujishima H, et al.  Preoperative evaluation of gastric cancer by endoscopic ultrasound. Gut. 1991;32:479–482
  81. de Manzoni G, Pedrazzani C, Di Leo A, et al.  Experience of endoscopic ultrasound in staging adenocarcinoma of the cardia. Eur J Surg Oncol. 1999;25:595–598
  82. MacDonald J, Gohmann J. Chemotherapy of advanced gastric cancer (Present status, future prospects). Semin Oncol. 1988;15(suppl 4):42–49
  83. Goh P, So J. Role of laparoscopy in the management of stomach cancer. Semin Surg Oncol. 1999;16:321–326
  84. Possik R, Franco E, Pires D, et al.  Sensitivity, specificity, and predictive value of laparoscopy for the staging of gastric cancer and for the detection of liver metastases. Cancer. 1986;58:1–6
  85. O’Brien M, Fitzgerald E, Lee G, et al.  A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. Am J Gastroenterol. 1995;90:2191–2194
  86. Stell D, Carter C, Stewart I, et al.  Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg. 1996;83:1260–1262
  87. Burke E, Karpeh M, Conlon K, et al.  Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997;225:262–267
  88. D’Ugo D, Persiani R, Caracciolo F, et al.  Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy. Surg Endosc. 1997;11:1159–1162
  89. Charukhchyan S, Lucas G. Laparoscopy and lesser sac endoscopy in gastric carcinoma operability assessment. Am Surg. 1998;64:160–164
  90. Feussner H, Omote K, Fink U, et al.  Pre-therapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy. 1999;31:342–347
  91. Lowy A, Mansfield P, Leach S, et al.  Laparoscopic staging for gastric cancer. Surgery. 1996;119:611–614
  92. Ajani J, Mansfield P, Lynch PM, et al.  Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol. 1999;17:2403–2411
  93. Adashek K, Sanger J, Longmire W. Cancer of the stomach. Review of consecutive ten year intervals. Ann Surg. 1979;189:6–10
  94. Conlon K, Karpeh M. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer. Semin Oncol. 1996;23:347–351
  95. Bemelman W, van Delden O, van Lanschot J, et al.  Laparoscopy and laparoscopic ultrasonography in staging of carcinoma of the esophagus and gastric cardia. J Am Coll Surg. 1995;181:421–425
  96. Romijn M, van Overhagen H, Spillenaar Bilgen E, et al.  Laparoscopy and laparoscopic ultrasonography in staging of esophageal and cardial carcinoma. Br J Surg. 1998;85:1010–1012
  97. Smith A, John T, Garden O, et al.  Role of laparoscopic ultrasonography in the management of patients with oesophagogastric cancer. Br J Surg. 1999;86:1083–1087
  98. Japanese Research Society for Gastric Cancer . Japanese Classification of Gastric Cancer. 2nd English edition. Tokyo, Japan: Kanehara; 1998;
  99. Burke E, Karpeh M, Conlon K, et al.  Peritoneal lavage cytology in gastric cancer (An independent predictor of outcome). Ann Surg Oncol. 1998;5:411–415
  100. Abe S, Yoshimura H, Tabara H, et al.  Curative resection of gastric cancer (Limitation of peritoneal lavage cytology in predicting the outcome). J Surg Oncol. 1995;59:226–229
  101. Kodera Y, Yamamura Y, Shimizu Y, et al.  Peritoneal washing cytology (Prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection). J Surg Oncol. 1999;72:60
  102. Yeung H, Macapinlac H, Karpeh M, et al.  Accuracy of FDG-PET in gastric cancer (Preliminary experience). Clin Positron Imaging. 1998;1:213–221
  103. De Potter T, Flamen P, Van Cutsem E, et al.  Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging. 2002;29:525–529
  104. Yoshioka T, Yamaguchi K, Kubota K, et al.  Evaluation of F-18-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med. 2003;44:690–699
  105. Turlakow A, Yeung H, Salmon A, et al.  Peritoneal carcinomatosis (Role of F-18-FDG PET). J Nucl Med. 2003;44:1407–1412
  106. Couper G, McAteer D, Wallis F, et al.  Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric. Br J Surg. 1998;85:1403–1406
  107. Palaia R, Cremona F, Delrio P, et al.  Sentinel node biopsy in gastric cancer. J Chemother. 1999;11:230–231
  108. Maruyama K, Sasako M, Kinoshita T, et al.  Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? Fundamental and new information on lymph-node dissection. Langenbecks Arch Surg. 1999;384:149–157
  109. Sano T, Katai H, Sasako M, et al.  Gastric lymphography and detection of sentinel nodes. Recent Results Cancer Res. 2000;157:253–258
  110. Siewert J, Sendler A. Potential and futility of sentinel node detection for gastric cancer. Recent Results Cancer Res. 2000;157:259–269
  111. Kosaka T, Ueshige N, Sugaya J, et al.  Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today. 1999;29:695–700
  112. Siewert J, Feith M, Werner M, et al.  Adenocarcinoma of the esophagogastric junction—Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232:353–360
  113. Wayman J, Dresner S, Raimes S, et al.  Transhiatal approach to total gastrectomy for adenocarcinoma of the gastric cardia. Br J Surg. 1999;86:536–540
  114. Harrison L, Karpeh M, Brennan M. Proximal gastric cancers resected via a transabdominal-only approach—Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg. 1997;225:678–683
  115. Siewert J. Modern staging and treatment of esophageal junction tumors. American College of Surgeons Clinical Congress. 2003;89:33

PII: S0093-7754(04)00235-0

doi: 10.1053/j.seminoncol.2004.04.014

Seminars in Oncology
Volume 31, Issue 4 , Pages 513-529 , August 2004

Article Tools

* Image Usage & Resolution